Showing results (1311-1320 of 1,350) with videos related to

Sort By:
Pageof 135
IEEE Life Sciences Letters|March 24, 2021
SCT Promoter Methylation is a Highly Discriminative Biomarker for Lung and Many Other CancersAdwait Sathe, Yu-An Zhang, Xiaotu Ma, et al.
Frontiers in Immunology|August 1, 2022
Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma-A Real-World Multicenter Study (RICE-Retro)Shujie Huang, Hansheng Wu, Chao Cheng, et al.
The Journal of Clinical Investigation|April 1, 2021
Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation testWenhua Liang, Zhiwei Chen, Caichen Li, et al.
Toxicology and Applied Pharmacology|August 14, 2025
Empagliflozin attenuates sorafenib-promoted renal ferroptosis and inflammation by targeting cyclooxygenase-2/prostaglandin E<sub>2</sub> axisMing-Kai Tsai, Wen-Chin Lee, Shih-Chung Huang, et al.
Plos Genetics|April 14, 2022
Abnormal global alternative RNA splicing in COVID-19 patientsChangli Wang, Lijun Chen, Yaobin Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to ImmunotherapyFeng Xie, Jianjun Zhang, Jiayin Wang, et al.
Nature Communications|September 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapyGuangchun Han, Guoliang Yang, Dapeng Hao, et al.
Immunity|September 15, 2021
Resident memory CD8<sup>+</sup> T cells in regional lymph nodes mediate immunity to metastatic melanomaAleksey K Molodtsov, Nikhil Khatwani, Jennifer L Vella, et al.
Gene|March 5, 2023
Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinomaShih-Chung Huang, Chao-Cheng Huang, Chou-Yuan Ko, et al.
Nature Communications|August 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cellsLisa Brunet, David Alexandre, Jiyoung Lee, et al.
Pageof 135